» Authors » Hengameh Mojdeganlou

Hengameh Mojdeganlou

Explore the profile of Hengameh Mojdeganlou including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 298
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
SeyedAlinaghi S, Pashaei A, Tantuoyir M, Karimi A, Mojdeganlou H, Nazarian N, et al.
Tanaffos . 2025 Feb; 23(2):102-114. PMID: 39959793
Background: There have been safety concerns regarding the COVID-19 vaccines because of their unprecedented speed of development. Therefore, systematic reviews are necessary to address these concerns and reduce public hesitancy...
2.
SeyedAlinaghi S, Shahidi R, Mojdeganlou H, Akhtaran F, Maroufi S, Parmis Maroufi S, et al.
J Health Popul Nutr . 2024 Jan; 43(1):16. PMID: 38287379
Background And Aims: A healthy diet play an important role in the prevention and even treatment of various diseases. Proper nutrition plays an important role in boosting of immune system....
3.
Mehraeen E, Akhtaran F, Faridrohani M, Afzalian A, Mojdeganlou H, Ghanbari Z, et al.
Infect Disord Drug Targets . 2023 Nov; 24(2):e311023222945. PMID: 37909430
Introduction: An asymptomatic population has the same infection as symptomatic individuals, so these individuals can unknowingly spread the virus. It is not possible to predict the rate of epidemic growth...
4.
Abbasi A, Ghaffarizadeh F, Mojdeganlou H
Int J Hematol Oncol Stem Cell Res . 2023 Aug; 17(2):100-105. PMID: 37637763
Breast cancer is the most common malignant tumor and cause of death in women. Factors that play role in tumor metastasis are lymph node involvement, lack of tumor differentiation and...
5.
SeyedAlinaghi S, Karimi A, Afsahi A, Mirzapour P, Varshochi S, Mojdeganlou H, et al.
Infect Disord Drug Targets . 2023 Jun; PMID: 37259934
Introduction: Since the beginning of the COVID-19 pandemic, face masks have been among the cornerstones of COVID-19 prevention. Therefore, evaluating their preventive effects against COVID-19 is crucial. This review aimed...
6.
SeyedAlinaghi S, Bagheri A, Razi A, Mojdeganlou P, Mojdeganlou H, Afsahi A, et al.
Arch Acad Emerg Med . 2023 May; 11(1):e28. PMID: 37215236
Introduction: Several clinical manifestations have been discovered for COVID-19 since the emergence of SARS-CoV-2, which can be classified into early, medium, and long-term complications. However, late complications can be present...
7.
SeyedAlinaghi S, Afsahi A, Shahidi R, Kianzad S, Pashaei Z, Mirahmad M, et al.
J Smok Cessat . 2023 May; 2023:7656135. PMID: 37214631
Introduction: Smoking status appears to lead to a poor prognosis in COVID-19 patients. However, findings from the studies conducted on this topic have not been consistent, and further exploration is...
8.
SeyedAlinaghi S, Karimi A, Mirzapour P, Salmani R, Razi A, Mojdeganlou H, et al.
Infect Disord Drug Targets . 2023 May; 23(7):29-38. PMID: 37138433
Introduction: Earlier reports described the possibility of higher SARS-CoV-2 infection and severity in patients with hematological malignancies. Given the importance and incidence of these malignancies, we aimed to systematically review...
9.
SeyedAlinaghi S, Afzalian A, Pashaei Z, Varshochi S, Karimi A, Mojdeganlou H, et al.
Health Sci Rep . 2023 Feb; 6(2):e1080. PMID: 36721396
Background And Aims: Alteration in humans' gut microbiota was reported in patients infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The gut and upper respiratory tract (URT) microbiota harbor a...
10.
Dehghani S, SeyedAlinaghi S, Karimi A, Afroughi F, Abshenas S, Azad K, et al.
Health Sci Rep . 2023 Jan; 6(1):e1042. PMID: 36644313
Introduction: Airborne transmission is the most  crucial mode of COVID-19 transmission. Therefore, disinfecting the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) aerosols float can have important implications in limiting COVID-19 transmission....